Antiarrhythmic therapy for narrow QRS supraventricular tachyarrhythmias in newborns and infants in the first year of life: Potent tools to be handled with care [PDF]
Supraventricular tachyarrhythmias pose a significant challenge in neonates and infants, particularly within the first year of life, where prompt and effective management is crucial.
Giovanni Domenico Ciriello +13 more
doaj +3 more sources
Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs [PDF]
The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj +2 more sources
Prediction of antiarrhythmic therapy effectiveness in children [PDF]
Aim. To optimize treatment tactics in children with arrhythmias based on the evaluation and prediction of the therapy efficacy.Material and methods. Prospective cohort study was performed from 2007 to 2017 A total of 100 patients aged 0 to 7 years with ...
L. I. Svintsova +2 more
doaj +2 more sources
Antiarrhythmic Drug Dosing in Children—Review of the Literature
Antiarrhythmic drugs represent a mainstay of pediatric arrhythmia treatment. However, official guidelines and consensus documents on this topic remain scarce. There are rather uniform recommendations for some medications (including adenosine, amiodarone,
Nathalie Oeffl +8 more
doaj +2 more sources
Identification of potentially effective antiarrhythmic drugs to individualize premature ventricular contraction therapy in patients without structural cardiac changes [PDF]
Aim. To individualize premature ventricular contraction (PVC) therapy in patients without structural cardiac changes by identifying potentially effective antiarrhythmic agents.Material and methods.
A. I. Olesin +3 more
doaj +2 more sources
Ventricular tachycardia characteristics and outcomes with catheter ablation vs. antiarrhythmic therapy: insights from the VANISH trial. [PDF]
Deyell MW +10 more
europepmc +2 more sources
EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION
Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF).Material and methods. 40 patients with paroxysmal AF were involved in open-
L. N. Chikhireva +3 more
doaj +3 more sources
Background: Catheter ablation is an effective treatment for atrial fibrillation (AF), primarily performed in patients who fail antiarrhythmic drugs. Whether early catheter ablation, as first-line therapy, is associated with improved clinical outcomes ...
Aminah Abdul Razzack +16 more
doaj +1 more source
Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy
Paroxysmal supraventricular tachycardias during pregnancy are rare; however, it can be a therapeutic challenge because of limitations about use of antiarrhythmic drug therapy and catheter ablation indication, due to the risk of radiation exposure to the ...
Ulises Rojel +5 more
doaj +1 more source
Feasibility of Radiofrequency Catheter Ablation in the Treatment of Atrial Fibrillation
Atrial fibrillation (AF) is a worldwide epidemic that has hit about 33 million people. In clinical studies, the efficacy of antiarrhythmic therapy and catheter ablation in the treatment of AF was compared, and controversial results were obtained ...
M. Meshkova, A. Doronin
doaj +1 more source

